Abstract
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
Vibeke Strand, David L Scott, Paul Emery, Joachim R Kalden, Josef S Smolen, Grant W Cannon, Peter Tugwell, Bruce Crawford and Leflunomide Rheumatoid Arthritis Investigators Groups
The Journal of Rheumatology April 2005, 32 (4) 590-601;
Vibeke Strand
David L Scott
Paul Emery
Joachim R Kalden
Josef S Smolen
Grant W Cannon
Peter Tugwell
In this issue
The Journal of Rheumatology
Vol. 32, Issue 4
1 Apr 2005
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
Vibeke Strand, David L Scott, Paul Emery, Joachim R Kalden, Josef S Smolen, Grant W Cannon, Peter Tugwell, Bruce Crawford, Leflunomide Rheumatoid Arthritis Investigators Groups
The Journal of Rheumatology Apr 2005, 32 (4) 590-601;
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
Vibeke Strand, David L Scott, Paul Emery, Joachim R Kalden, Josef S Smolen, Grant W Cannon, Peter Tugwell, Bruce Crawford, Leflunomide Rheumatoid Arthritis Investigators Groups
The Journal of Rheumatology Apr 2005, 32 (4) 590-601;